Obviously, anaphylaxis is an unavoidable aspect of the practice of medicine. With the growing use of polypharmacy and the present epidemic of allergic disease, its incidence is increasing [1].
Although it is not possible to prevent all such episodes, some general preventive measures can reduce the frequency and severity of these events (Table 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Warner JO (1997) Anaphylaxis; the latest allergy epIDemic. Pediatr Allergy Immunol 18:1–2
Lieberman P (2003) Use of epinephrine in treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 3:313–318
Webb L, Lieberman P (2006) Anaphylaxis: a review of 601 cases. Ann Allergy Immunol 97:39–43
Lieberman P, Kemp SF, Oppenheimer J, Lang DM, Bernstein IL, Nicklas RA (2005) Letter reply. J Allergy Clin Immunol 116:933–936
Lieberman P (2003) Anaphylaxis and anaphylactoID reactions. In: Allergy: Principles and Practice, edition 6, Adkinson F, Yunginger J, Busse W, Bochner B, Holgate S, Simons FER (eds) (Mosby, an affiliate of Elsevier, US) pp 1497–1522
Physicians Desk Reference (PDR) (2005) Thomson, page 1186
Physicians Desk Reference (PDR) (2005) Thomson, page 732
Mink SN, Simons FER, Simons KJ, et al. (2004) Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 34(11):1776–1783
Gei A, Pachecho L, Van Hook J (2003) The use of continuous infusion of epinephrine for anaphylactic shock during labor. Obstet Gynecol 102:1332–1335
Brown SGA (2005) Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 5:369–364
Lieberman P, Kemp S, Oppenheimer J, Lang D, Bernstein I, Nicklas R (2005) The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115:S483–S523 (supplement)
Brown SGA, Blackman KE, Stenlake V, Heddle RJ (2004) Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 21:149–154
Schummer W, Schummer C, Wippermann J (2004) Anaphylactic shock: is vasopressin the drug of choice? Anaest 101:1025–1027
Wenzel V, Krismer AC, Arantz HR(2004) A comparison of vasopressin and epinephrine for out of hospital cardiopulmonary resuscitation. N Engl J Med 350:105–113
Stiell IG, Herbert PC, Wells GA (2001) Vasopressin versus epinephrine for in hospital cardiac arrest: a randomized controlled trial. Lancet 358:105–109
Sheth SS, Del Duca D, Ergina P, Clarke AE (2007) Methylene blue as a treatment for refractory anaphylaxis. J Allergy Clin Immunol
Lin RY, Curry A, Pesola G (2000) Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med 36:462–468
Ellis AK, Day JH (2007) IncIDence and characteristics of biphasic anaphylaxis: a perspective evaluation of 103 patients. Ann Allergy Asthma Immunol 98:64–69
Lieberman P (2005) Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95:217–226
Sicherer S, Simons EFR (2005) Quandaries in prescribing emergency action plans and self-injectable epinephrine for first-aID management of anaphylaxis in the community. J Allergy Clin Immunol 115:575–583
Simons FE, Gu X, Simons KJ (2001) Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 108:871–873
Simons FER, Gu X, Simons KJ (2000) Outdated EpiPen and EpiPen Junior autoinjectors: past their prime? J Allergy Clin Immunol 105:1025–1030
Kelso JM (2006) A second dose of epinephrine for anaphylaxis: how often needed and how to carry. J Allergy Clin Immunol 117(2):464–465
Soar J, Deakin C, Nolen J (2005) European Resuscitation Council guIDelines for resuscitation 2005, Section 7. Cardiac arrest in special circumstances. Resuscitation 6751:S135–S170 (supplement).
Pumphrey RSH (2004) Fatal anaphylaxis in the UK, 1992–2001. In: Anaphylaxis (publication of The Novartis Foundation, John Wiley & Sons Ltd, summary of Novartis Foundation Symposium 257, 2004. John Wiley & Sons Ltd, the Atrium, Southern Gate, Chichester, UK), pp 116–132
Pumphrey RSH, Gowland M (2007) Further fatal allergic reactions to food in the United Kingdom, 1999 2006. J Allergy Clin Immunol 19:1018
Pumphrey RSH (2003) Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112:451– 452 (Letter to Editor)
Rotskoff BD, Greenberger PA, Lifschultz B (2003) Fatal anaphylaxis: postmortem findings and associated comorbID disease. J Allergy Clin Immunol 111:S101 (abstract)
Bock SA, Munoz-Furlong A, Sampson HH (2007) Further fatalities caused by anaphylactic reactions to food, 2001–2006. J Allergy Clin Immunol 119:1016–1018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lieberman, P. (2009). Management of Anaphylaxis. In: Pawankar, R., Holgate, S.T., Rosenwasser, L.J. (eds) Allergy Frontiers: Therapy and Prevention. Allergy Frontiers, vol 5. Springer, Tokyo. https://doi.org/10.1007/978-4-431-99362-9_18
Download citation
DOI: https://doi.org/10.1007/978-4-431-99362-9_18
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-99361-2
Online ISBN: 978-4-431-99362-9
eBook Packages: MedicineMedicine (R0)